# Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

> **NCT03684278** · PHASE2 · RECRUITING · sponsor: **University of Liverpool** · enrollment: 290 (estimated)

## Conditions studied

- Acute Pancreatitis

## Interventions

- **DRUG:** Infusion of 5 mg/kg Infliximab
- **DRUG:** Infusion of 10 mg/kg Infliximab
- **OTHER:** 0.9% Sodium Chloride (Placebo)

## Key facts

- **NCT ID:** NCT03684278
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03684278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03684278, "Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03684278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*